Huston Thad Allen bought ARTV
March 10, 2026 · Form 4 insider transaction
Huston Thad Allen bought 220,000 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
220,000
Price
$0.00
Total value
N/A
InsiderHuston Thad Allen
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 10, 2026
Filing dateMarch 10, 2026
Shares owned after220,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock unit award granted under the Issuer's 2025 Inducement Plan.